Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.87 +0.01 (+0.54%)
At close: Nov 11, 2026 · 4:00 PM EST

Lexicon Pharmaceuticals (LXRX) Price to Earnings (2019 - 2021)

Updated

Lexicon Pharmaceuticals' (LXRX) Price to Earnings stood at 17.41 in Q2 2021, up 219.2% from 5.46 a year earlier.

Analysis

Lexicon Pharmaceuticals (LXRX) Price to Earnings (2019 - 2021) Analysis & Trends

For FY2019, Lexicon Pharmaceuticals' Price to Earnings came in at 3.41.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Lexicon Pharmaceuticals 831.26 Mn 190.55 Mn 11.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 17.41
Jun 30, 2020 5.46
Mar 31, 2020 2.44
Dec 31, 2019 3.41
Sep 30, 2019 1.94
API Access

Lexicon Pharmaceuticals Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=LXRX&period=max&api_key=YOUR_API_KEY